Why Market Size Forecasters?
- Reports at Lowest Prices - Guaranteed
- Fastest Growing Research Reports’ Database
- Easy Customization Options
- 24 X 7 Support Commitment
- Certified, Safe & Secured Payments
About Antiretroviral Therapy The antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART market include the rising awareness of retroviral infection, aggressive innovation in diagnostic techniques, the introduction of novel drugs through significant investments made in R&D, and high unmet needs in the retrovirus infection treatment domain. Technavio?s analysts forecast the global antiretroviral therapy market to grow at a CAGR of 2.64% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global antiretroviral therapy market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs. The market is divided into the following segments based on geography: ? Americas ? APAC ? EMEA Technavio's report, Global Antiretroviral Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors ? Gilead ? ViiV Healthcare ? Janssen Pharmaceuticals ? F. Hoffmann-La Roche Other prominent vendors ? Abbvie ? Boehringer Ingelheim ? Bionor Pharma ? Vertex Pharmaceuticals ? Mylan Market driver ? Rising awareness of retroviral infection ? For a full, detailed list, view our report Market challenge ? High cost of antiretroviral drugs ? For a full, detailed list, view our report Market trend ? Significant pipeline ? For a full, detailed list, view our report Key questions answered in this report ? What will the market size be in 2021 and what will the growth rate be? ? What are the key market trends? ? What is driving this market? ? What are the challenges to market growth? ? Who are the key vendors in this market space? You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION ? Market outline PART 05: DISEASE OVERVIEW PART 06: MARKET LANDSCAPE ? Market overview ? Market size and forecast ? Five forces analysis PART 07: PIPELINE LANDSCAPE PART 08: MARKET SEGMENTATION BY DRUG CLASS ? Multiclass combination products ? NRTIs ? Integrase inhibitors ? NNRTIs ? Others PART 09: REGIONAL LANDSCAPE ? Regional comparison ? ART market in Americas ? ART market in EMEA ? ART market in APAC ? Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES ? Market drivers ? Market challenges PART 12: MARKET TRENDS ? Significant pipeline ? Advanced formulations ? Funding and treatment initiatives PART 13: VENDOR LANDSCAPE ? Vendor landscape PART 14: KEY VENDOR ANALYSIS ? Gilead ? ViiV Healthcare ? Janssen Pharmaceuticals ? F. Hoffmann-La Roche ? Other prominent vendors PART 15: APPENDIX ? List of abbreviations List of Exhibits Exhibit 01: Global ART market Exhibit 02: Global ART market 2016-2021 ($ millions) Exhibit 03: Five forces analysis Exhibit 04: Pipeline landscape by development phase Exhibit 05: Key clinical trials Exhibit 06: Global ART market by drug class 2016 Exhibit 07: Global ART market by drug class 2021 Exhibit 08: Global ART market by multiclass combination products 2016-2021 ($ millions) Exhibit 09: Global ART market by NRTIs 2016-2021 ($ millions) Exhibit 10: Global ART market by integrase inhibitors 2016-2021 ($ millions) Exhibit 11: Global ART market by NNRTIs 2016-2021 ($ millions) Exhibit 12: Global ART market by others 2016-2021 ($ millions) Exhibit 13: Global ART market: Regional landscape Exhibit 14: Regional comparison Exhibit 15: ART market in Americas 2016-2021 ($ millions) Exhibit 16: ART market in Americas ? Year over year growth 2017-2021 Exhibit 17: ART market in EMEA 2016-2021 ($ millions) Exhibit 18: ART market in EMEA ? Year over year growth 2017-2021 Exhibit 19: ART market in APAC 2016-2021 ($ millions) Exhibit 20: ART market in APAC ? Year over year growth 2017-2021 Exhibit 21: Gilead: Key highlights Exhibit 22: Gilead: Strength assessment Exhibit 23: Gilead: Strategy assessment Exhibit 24: Gilead: Opportunity assessment Exhibit 25: ViiV Healthcare: Key highlights Exhibit 26: ViiV Healthcare: Strength assessment Exhibit 27: ViiV Healthcare: Strategy assessment Exhibit 28: ViiV Healthcare: Opportunity assessment Exhibit 29: Janssen Pharmaceuticals: Key highlights Exhibit 30: Janssen Pharmaceuticals: Strength assessment Exhibit 31: Janssen Pharmaceuticals: Strategy assessment Exhibit 32: Janssen Pharmaceuticals: Opportunity assessment Exhibit 33: F. Hoffmann-La Roche: Key highlights Exhibit 34: F. Hoffmann-La Roche: Strength assessment Exhibit 35: F. Hoffmann-La Roche: Strategy assessment Exhibit 36: F. Hoffmann-La Roche: Opportunity assessment
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Why Market Size Forecasters?